US OptionsDetailed Quotes
APLS240816P55000
- 17.90
- +1.80+11.18%
15min DelayClose Aug 16 15:59 ET
17.90High17.90Low
17.90Open16.10Pre Close1 Volume5 Open Interest55.00Strike Price1.79KTurnover4005.02%IV0.40%PremiumAug 16, 2024Expiry Date17.75Intrinsic Value100Multiplier-1DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type-0.8976Delta0.0173Gamma2.05Leverage Ratio-51.3608Theta0.0000Rho-1.84Eff Leverage0.0005Vega
Apellis Pharmaceuticals Stock Discussion
Sign in to post a comment
$Emergent BioSolutions (EBS.US)$👀 big news out WHO Says Expert Committee Will Propose Adopti - moomoo $Apellis Pharmaceuticals (APLS.US)$ $Puma Biotechnology (PBYI.US)$ $Novocure (NVCR.US)$
1
$Apellis Pharmaceuticals (APLS.US)$ CORRECTION: Apellis Pharmaceuticals Q2 2024 GAAP EPS $(0.30) Beats $(0.32) Estimate, Sales $199.70M Beat $191.51M Estimate
2
$Apellis Pharmaceuticals (APLS.US)$ 🥱 as i was saying the other day
1
4
2X 
$Apellis Pharmaceuticals (APLS.US)$ i made a lot of money on this stock
1
$Apellis Pharmaceuticals (APLS.US)$ I'm shocked this had not done anything. it hit bottom at 19.83 after the big scare panic sell off from mid 80s , bounce back up past 70. stupid corporate keeps selling off scaring investors. this is actually bargain price for this company
2
No comment yet
EZ_money OP : Vaccine developers for monkeypox include Bavarian Nordic (OTCPK:BVNKF) (OTCPK:BVNRY), Emergent BioSolutions (EBS), and Chimerix (CMRX).